Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial: International Journal of Endocrinology

J. B. Ernst; A. Tomaschitz; M.R. Grubler; M. Gaksch; K. Kienreich; N. Verheyen; W. Marz; S. Pilz; A. Zittermann

doi:10.1155/2016/6836402

Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial: International Journal of Endocrinology

J. B. Ernst, A. Tomaschitz, M.R. Grubler, M. Gaksch, K. Kienreich, N. Verheyen, W. Marz, S. Pilz, A. Zittermann

Epidemiology and Data Science

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Epidemiological evidence suggests that circulating 25-hydroxyvitamin D (25OHD) levels are inversely associated with hemoglobin (Hb) levels and anemia risk. We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels 50 nmol/L. Themean (95% confidence interval) vitamin D effect on Hb levels was 0.04 (-0.14 to 0.22) g/dL (P = 0.661). Moreover, vitamin D treatment did not influence anemic status significantly (P > 0.999). Likewise, vitamin D had no significant effect on Hb levels in the subgroups of anemic patients or in patients with initial 25OHD levels

Original language	English
Article number	6836402
Number of pages	7
Journal	International Journal of Endocrinology
DOIs	https://doi.org/10.1155/2016/6836402
Publication status	Published - 2016

Access to Document

10.1155/2016/6836402

Cite this

@article{a40b0acc8dc3421b8cb06800d4f8b007,

title = "Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial: International Journal of Endocrinology",

abstract = "Epidemiological evidence suggests that circulating 25-hydroxyvitamin D (25OHD) levels are inversely associated with hemoglobin (Hb) levels and anemia risk. We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels 50 nmol/L. Themean (95% confidence interval) vitamin D effect on Hb levels was 0.04 (-0.14 to 0.22) g/dL (P = 0.661). Moreover, vitamin D treatment did not influence anemic status significantly (P > 0.999). Likewise, vitamin D had no significant effect on Hb levels in the subgroups of anemic patients or in patients with initial 25OHD levels ",

author = "Ernst, {J. B.} and A. Tomaschitz and M.R. Grubler and M. Gaksch and K. Kienreich and N. Verheyen and W. Marz and S. Pilz and A. Zittermann",

note = "ISI Document Delivery No.: DF6TD Times Cited: 0 Cited Reference Count: 39 Ernst, Jana B. Tomaschitz, Andreas Gruebler, Martin R. Gaksch, Martin Kienreich, Katharina Verheyen, Nicolas Maerz, Winfried Pilz, Stefan Zittermann, Armin Grubler, Martin R./0000-0002-1761-2914 0 6 8 HINDAWI PUBLISHING CORP NEW YORK INT J ENDOCRINOL",

year = "2016",

doi = "10.1155/2016/6836402",

language = "English",

journal = "International Journal of Endocrinology",

issn = "1687-8337",

publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial

T2 - International Journal of Endocrinology

AU - Ernst, J. B.

AU - Tomaschitz, A.

AU - Grubler, M.R.

AU - Gaksch, M.

AU - Kienreich, K.

AU - Verheyen, N.

AU - Marz, W.

AU - Pilz, S.

AU - Zittermann, A.

N1 - ISI Document Delivery No.: DF6TD Times Cited: 0 Cited Reference Count: 39 Ernst, Jana B. Tomaschitz, Andreas Gruebler, Martin R. Gaksch, Martin Kienreich, Katharina Verheyen, Nicolas Maerz, Winfried Pilz, Stefan Zittermann, Armin Grubler, Martin R./0000-0002-1761-2914 0 6 8 HINDAWI PUBLISHING CORP NEW YORK INT J ENDOCRINOL

PY - 2016

Y1 - 2016

N2 - Epidemiological evidence suggests that circulating 25-hydroxyvitamin D (25OHD) levels are inversely associated with hemoglobin (Hb) levels and anemia risk. We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels 50 nmol/L. Themean (95% confidence interval) vitamin D effect on Hb levels was 0.04 (-0.14 to 0.22) g/dL (P = 0.661). Moreover, vitamin D treatment did not influence anemic status significantly (P > 0.999). Likewise, vitamin D had no significant effect on Hb levels in the subgroups of anemic patients or in patients with initial 25OHD levels

AB - Epidemiological evidence suggests that circulating 25-hydroxyvitamin D (25OHD) levels are inversely associated with hemoglobin (Hb) levels and anemia risk. We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels 50 nmol/L. Themean (95% confidence interval) vitamin D effect on Hb levels was 0.04 (-0.14 to 0.22) g/dL (P = 0.661). Moreover, vitamin D treatment did not influence anemic status significantly (P > 0.999). Likewise, vitamin D had no significant effect on Hb levels in the subgroups of anemic patients or in patients with initial 25OHD levels

U2 - 10.1155/2016/6836402

DO - 10.1155/2016/6836402

M3 - Article

C2 - 27006655

JO - International Journal of Endocrinology

JF - International Journal of Endocrinology

SN - 1687-8337

M1 - 6836402

ER -